Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP vs Corticosteroid for Greater Trochanteric Pain Syndrome
NCT02031367Phase 1Unknown
- Sponsor
- Carl R. Darnall Army Medical Center
- Start
- Mar 2014
- Primary completion
- Dec 2016
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of autologous platelet-rich plasma in greater trochanteric pain syndrome (GTPS) (2 arms), sponsored by Carl R. Darnall Army Medical Center. Primary endpoint: Pain (Visual Analog Scale) at 1 year. Status: unknown.
02
Drugs
autologous platelet-rich plasma
03
Conditions
greater trochanteric pain syndrome (GTPS)
Beyond the preview
Go deeper on NCT02031367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02031367.